BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17553085)

  • 1. Methyl 3-[3',4'-(methylenedioxy)phenyl]-2-methyl glycidate: an ecstasy precursor seized in Sydney, Australia.
    Collins M; Heagney A; Cordaro F; Odgers D; Tarrant G; Stewart S
    J Forensic Sci; 2007 Jul; 52(4):898-903. PubMed ID: 17553085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of N-tert-butoxycarbonyl-MDMA: a new MDMA precursor.
    Collins M; Donnelly C; Cameron S; Tahtouh M; Salouros H
    Drug Test Anal; 2017 Mar; 9(3):399-404. PubMed ID: 27574107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-cyanomethyl-N-methyl-1-(3',4'-methylenedioxyphenyl)-2-propylamine: an MDMA manufacturing by-product.
    Salouros H; Collins M; Tarrant G; George AV
    J Forensic Sci; 2008 Sep; 53(5):1083-91. PubMed ID: 18637869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantitation of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in human urine by 1H NMR spectroscopy. Application to five cases of intoxication.
    Liu J; Decatur J; Proni G; Champeil E
    Forensic Sci Int; 2010 Jan; 194(1-3):103-7. PubMed ID: 19926414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method.
    Visser HA; Visser-van Leeuwen M; Huizer H
    Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase extraction for profiling of ecstasy tablets.
    Rashed AM; Anderson RA; King LA
    J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
    Carter JF; Titterton aE; Murray M; Sleeman R
    Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum-chemical, NMR and X-ray diffraction studies on (+/-)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane.
    Zapata-Torres G; Cassels BK; Parra-Mouchet J; Mascarenhas YP; Ellena J; De Araujo AS
    J Mol Graph Model; 2008 Jun; 26(8):1296-305. PubMed ID: 18280190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities.
    Plummer CM; Breadon TW; Pearson JR; Jones OAH
    Sci Justice; 2016 May; 56(3):223-230. PubMed ID: 27162021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis.
    Renton RJ; Cowie JS; Oon MC
    Forensic Sci Int; 1993 Aug; 60(3):189-202. PubMed ID: 7901132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the synthetic origin of amphetamines by 2H NMR spectroscopy.
    Armellin S; Brenna E; Fronza G; Fuganti C; Pinciroli M; Serra S
    Analyst; 2004 Feb; 129(2):130-3. PubMed ID: 14752555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variability of ecstasy tablets composition in Brazil.
    Togni LR; Lanaro R; Resende RR; Costa JL
    J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
    Verweij AM
    Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supported liquid-liquid extraction of the active ingredient (3,4-methylenedioxymethylamphetamine) from ecstasy tablets for isotopic analysis.
    de Korompay A; Hill JC; Carter JF; NicDaeid N; Sleeman R
    J Chromatogr A; 2008 Jan; 1178(1-2):1-8. PubMed ID: 18070626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair.
    Wu YH; Lin KL; Chen SC; Chang YZ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impurity profiling/comparative analyses of samples of 1-phenyl-2-propanone.
    Krawczyk W; Kunda T; Perkowska I; Dudek D
    Bull Narc; 2005; 57(1-2):33-62. PubMed ID: 21338015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of target odor compounds from seized ecstasy tablets for canine detection.
    Macias MS; Furton KG
    J Forensic Sci; 2011 Nov; 56(6):1594-600. PubMed ID: 21827456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.